We serve Chemical Name:2-Aminomethyl-1-Boc-piperidine CAS:370069-31-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Aminomethyl-1-Boc-piperidine
CAS.NO:370069-31-1
Synonyms:1-Boc-2-(Aminomethyl)piperidine;2-Methyl-2-propanyl 3-(aminomethyl)-1-piperidinecarboxylate;MFCD01317791;1-Boc-(2-Aminomethyl)piperidine;tert-butyl 2-(aminomethyl)piperidine-1-carboxylate
Molecular Formula:C11H22N2O2
Molecular Weight:214.305
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:299.4±13.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.482
PSA:55.56000
Exact Mass:214.168121
LogP:1.07
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3082 9/PG 3
Packing Group:
Contact us for information like 1-Boc-2-(Aminomethyl)piperidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-butyl 2-(aminomethyl)piperidine-1-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methyl-2-propanyl 3-(aminomethyl)-1-piperidinecarboxylate Use and application,1-Boc-2-(Aminomethyl)piperidine technical grade,usp/ep/jp grade.
Related News: The ability of a CDMO to lay down good quality audits, knowledge of equipment, packaging configurations, and good capability building of resources, helps in determining a competent CDMO partner. d-galacturonic acid manufacturers Less than three weeks after unveiling the construction of a new fill-finish facility in Morocco, the Sweden-based company announced it was undergoing construction of another fill-finish plant in India. Fondaparinux Sodium suppliers SARS-CoV-2 has evolved mutations that severely compromise the neutralizing activities of multiple IgG monoclonal antibodies, including those under clinical trials and authorized for emergency use.
Therefore, developing new antibody therapies that can overcome these challenges is an urgent unmet need, and we are pleased with the data published today,” An said.
“Synergizing the strengths of multiple institutions from academia and industry is the key to the rapid translation from ideas to therapeutic candidates.
This is another example of such success. The cross-institutional and academic-industry collaborations should be expanded to other disease indications,” said Pei-Yong Shi, PhD, professor and co-senior author of the study from the Department of Biochemistry and Molecular Biology at UTMB Health.
This antibody has been licensed to biotech partner IGM Biosciences for drug development.
“The ability to use potently neutralizing IgM antibodies against SARS-CoV-2 with broad coverage of VOCs, VOIs, and viral escape mutants, is a very exciting application of the IGM platform,” said Fred Schwarzer, CEO of IGM Biosciences.
“We are grateful to our collaborators at UTHealth, UTMB Health, and our scientists at IGM for the exceptional work described in Nature today. 1-(Cbz-amino)cyclohexanecarboxylic Acid vendor & factory.
Therefore, developing new antibody therapies that can overcome these challenges is an urgent unmet need, and we are pleased with the data published today,” An said.
“Synergizing the strengths of multiple institutions from academia and industry is the key to the rapid translation from ideas to therapeutic candidates.
This is another example of such success. The cross-institutional and academic-industry collaborations should be expanded to other disease indications,” said Pei-Yong Shi, PhD, professor and co-senior author of the study from the Department of Biochemistry and Molecular Biology at UTMB Health.
This antibody has been licensed to biotech partner IGM Biosciences for drug development.
“The ability to use potently neutralizing IgM antibodies against SARS-CoV-2 with broad coverage of VOCs, VOIs, and viral escape mutants, is a very exciting application of the IGM platform,” said Fred Schwarzer, CEO of IGM Biosciences.
“We are grateful to our collaborators at UTHealth, UTMB Health, and our scientists at IGM for the exceptional work described in Nature today. 1-(Cbz-amino)cyclohexanecarboxylic Acid vendor & factory.
